Age and sex differences in efficacy of treatments for type 2 diabetes

JAMA

2025-02-03

(Press-News.org) About The Study: This systematic review and network meta-analysis of 601 eligible trials found that sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1 receptor agonists were associated with lower risk of major adverse cardiovascular events. Analysis of age × treatment interactions suggested that SGLT2 inhibitors were more cardioprotective in older than in younger people despite smaller reductions in hemoglobin A1c; GLP-1 receptor agonists were more cardioprotective in younger people.

Corresponding Author: To contact the corresponding author, Peter Hanlon, PhD, email peter.hanlon@glasgow.ac.uk.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2024.27402)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.27402?guestAccessKey=d9fad6f3-fe27-466e-be4c-ee5936e89378&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020325

END

ELSE PRESS RELEASES FROM THIS DATE:

Octopuses have some of the oldest known sex chromosomes

2025-02-03

The octopus just revealed another one of its secrets: what determines its sex. University of Oregon researchers have identified a sex chromosome in the California two-spot octopus. This chromosome has likely been around for 480 million years, since before octopuses split apart from the nautilus on the evolutionary tree. That makes it one of the oldest known animal sex chromosomes. The finding also is evidence that octopuses and other cephalopods, a class of sea animals that includes squid and nautiluses, do use chromosomes to determine their sex, answering a longstanding mystery among biologists. “Cephalopods are already such interesting creatures, ...

High-yield rice breed emits up to 70% less methane

2025-02-03

Rice cultivation is responsible for around 12% of global methane emissions, and these emissions are expected to increase with global warming and as the human population continues to grow. Now, scientists have identified chemical compounds released by rice roots that determine how much methane the plants emit. On February 3 in the Cell Press journal Molecular Plant, they report that this information enabled them to breed a new strain of rice that emits up to 70% less methane. “This study shows that you can have low methane and ...

Long COVID prevalence and associated activity limitation in US children

2025-02-03

About The Study: In 2023, post–COVID condition (PCC) continued to affect U.S. children at similar levels as 2022 and to have similar sociodemographic patterns. The large proportion of children experiencing PCC with any activity limitation highlights the need to examine the severity of activity limitation, functional outcomes, and days lost from school. Corresponding Author: To contact the corresponding author, Nicole D. Ford, PhD, MPH, email yex9@cdc.gov. To access the embargoed study: Visit our For The Media website ...

Intersection of race and rurality with health care–associated infections and subsequent outcomes

2025-02-03

About The Study: This cohort study of hospitalized adults identified inequities related to race and rurality in health care–associated infections (HAIs) and adverse outcomes from HAIs. These findings suggest that factors such as structural racism and disinvestment in rural communities may be associated with individual HAI risk and post-HAI outcomes. Future work to further understand the reasons underpinning these disparities and methods to address structural factors through policy and process changes are critical to ...

Risk of attempted and completed suicide in persons diagnosed with headache

2025-02-03

About The Study: The results of this cohort study revealing the robust and persistent association of headache diagnoses with attempted and completed suicide suggest that behavioral health evaluation and treatment may be important for these patients. Corresponding Author: To contact the corresponding author, Holly Elser, MD, PhD, email holly.elser@pennmedicine.upenn.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaneurol.2024.4974) Editor’s Note: Please see the article for ...

Adolescent smartphone use during school hours

2025-02-03

About The Study: Using passive sensing on a sample of U.S. adolescents, this study found half of adolescents use their smartphones during school for at least 66 minutes daily, primarily using messaging and social media. These findings extend a prior study limited to Android devices that found adolescents spent a median of 43 minutes on their phones during school. Corresponding Author: To contact the corresponding author, Lauren Hale, PhD, email Lauren.Hale@stonybrookmedicine.edu. To ...

Alarming rise in rates of advanced prostate cancer in California

2025-02-03

Alarming Rise in Rates of Advanced Prostate Cancer in California Following a change in screening guidelines, the incidence went up across the state, even more than it has nationally. The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study by UC San Francisco. After declining for many years, the death rate from the disease also plateaued in most regions across the state. The findings reinforce the need for screening that can identify potentially fatal tumors without raising false alarms about ones that pose no threat to the patient. The ...

Nearly half of adults mistakenly think benefits of daily aspirin outweigh risks

2025-02-03

For years, healthy older adults were advised by doctors to take a low-dose aspirin daily as a way to reduce the risk of heart attack. But in March 2019, the American College of Cardiology and the American Heart Association (AHA) announced new guidelines and no longer routinely recommended a daily dose of aspirin for healthy adults over the age of 70 because the risk of gastrointestinal bleeding outweighs the benefits. Nearly five years later, many Americans still have not received the message. The Annenberg Public Policy Center (APPC) of the University of Pennsylvania finds in a new health survey that nearly half (48%) of U.S. ...

Cardiovascular disease medications underused globally

2025-02-03

Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature mortality rates, according to study published today in JACC, the flagship journal of the American College of Cardiology. The study observed participants with CVD from 17 countries over 12 years and found that medication use remains low with little improvement. Secondary prevention of CVD focuses on preventing further health problems in people already diagnosed with CVD. This includes managing risk factors through lifestyle changes, medications and ...

Amazon Pharmacy's RxPass program improves medication adherence, helps prime members save money, study finds

2025-02-03

Approximately half of all Americans do not take their medication as prescribed by their doctor. This medication non-adherence causes an estimated 125,000 additional deaths and as much as $300 billion a year in additional medical appointments, emergency department visits, and hospitalizations. A new study published in the Journal of the American Medical Association (JAMA) Network Open finds Amazon Pharmacy’s subscription service for common medications, RxPass, leads to significant improvements in medication adherence while reducing out-of-pocket costs for patients. This first-of-its-kind study evaluated the potential of subscription models to support prescription medication access ...

LAST 30 PRESS RELEASES:

The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds